Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +50.81%
#3 DOVU DOVU +50.51%
#4 Cross Cross +49.17%
#5 Black Phoenix Black Phoenix +34.33%
#6 Velvet Velvet +32.01%
#7 OVERTAKE OVERTAKE +22.01%
#8 Cap Cap +17.55%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.87%
#10 Movement Movement +13.76%
Coin of the day
Glidr Glidr
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Agentix Corp. Agentix Corp.

Agentix Corp.

AGTX
Clasificación en acciones #38792
Agentix Corp., a company in the clinical development phase, specializes in the... Agentix Corp., a company in the clinical development phase, specializes in the discovery and commercialization of therapeutic agents aimed at treating metabolic disorders. Its pipeline includes two primary candidates: AGTX-2004, a peripherally-acting CB1 receptor antagonist, which has exhibited effectiveness in animal studies for both obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, also demonstrating positive results in animal models for obesity and non-alcoholic fatty liver diseases. The company was founded in 2013, initially known as FairWind Energy, Inc., before officially changing its name to Agentix Corp. in June 2019. Its operations are based in Dana Point, California.
Precio por acción
$0.02
Última sincronización: 2026-08-13
Capitalización bursátil
$801.34K
Cambio (1 día)
0.00%
Cambio (1 año)
-18.70%
País
US
Comercio Agentix Corp. (AGTX)

Categoría

Healthcare
Historial del precio de la acción de Agentix Corp. (AGTX)
Precio más alto de cierre: $0.02 el 2026-08-01

Precio más bajo de cierre: $13.07 el 2015-08-01
Historial del precio de la acción de Agentix Corp. desde 2015 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -6.56%
2025 -78.30%
2024 515.58%
2023 -72.91%
2022 -82.45%
2021 61.22%
2020 -98.30%
2019 128.57%
2018 -65.57%
2017 13.66%
2016 21.09%
2015 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $506.92 29.88%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $843.33 29.26%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE